Ensuring Access to Clinical Trials Act Archives - NORD (National Organization for Rare Disorders)

Scroll
To Top

donate

Archives for: September 29th, 2015

NORD Issues Statement Applauding the Approval of Ensuring Access to Clinical Trials Act

Written by Jennifer Huron on September 29, 2015

The following statement was issued by Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), on yesterday’s approval of the Ensuring Access to Clinical Trials Act (S. 139) in the United States House of Representatives.

The House of Representatives echoed the U.S. Senate and… Read More

Ensuring Access to Clinical Trials Act of 2015 Passes in the U.S. Senate

Written by Jennifer Huron on July 17, 2015

A win for the rare disease community

Yesterday, the U.S. Senate passed the Ensuring Access to Clinical Trials Act of 2015 (S 139), which NORD has supported. The bill would make permanent the Improving Access to Clinical Trials Act of 2009 (IACT). Without… Read More

Tweets From NORD

The #RareDisease of the Week is Ehlers-Danlos Syndrome. Help make an impact for EDS patients by making a donation t… https://t.co/niLcLU18IF2 hours ago
The Jansen's Foundation (@NeenaNizar) together w/ Omaha Children's Hospital announced its 1st Skeletal Dysplasias C… https://t.co/RrAg5EE8W73 hours ago
Know someone affected by mitochondrial disease? @MitoAction invites you to join them for their Family Weekend at Vi… https://t.co/X5VP0TqTHH6 hours ago
Don't wait! Register NOW for the #NORDSummit. After today, registration rates increase significantly! Get your tick… https://t.co/m0sBjF6wsX8 hours ago

Follow @RareDiseases

Alone we are rare. Together we are strong.®

For Patients and Families

For Industry

For Clinicians and Researchers

For Patient Organizations

Advocate

Get Involved

Home

About

News

Events

Contact

Careers

Brand Usage Guidelines

Sign Up for NORD News!
For Email Newsletters you can trust.

Follow NORD

Site Map

Website Credits

Privacy

Copyright ©2018 NORD - National Organization for Rare Disorders, Inc. All rights reserved. NORD is a registered 501(c)(3) charity organization. Please note that NORD provides this information for the benefit of the rare disease community. NORD is not a medical provider or health care facility and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder.